Literature DB >> 28939949

Focal segmental glomerulosclerosis associated with cutaneous and systemic plasmacytosis.

Shinsuke Isobe1, Naro Ohashi2, Naoko Katahashi2, Sayaka Ishigaki2, Naoko Tsuji3, Takayuki Tsuji2, Akihiko Kato3, Yoshihide Fujigaki4, Akira Shimizu5, Hideo Yasuda2.   

Abstract

Cutaneous and systemic plasmacytosis (CSP) is a rare lymphoproliferative disorder that mainly affects middle-aged Asian individuals. Although Castleman disease is often complicated with various renal involvements, glomerulonephritis associated with CSP, which is considered as a variant of Castleman disease, is rare. This report presents the case of a 41-year-old Japanese man with nephrotic syndrome associated with CSP. Renal biopsy findings showed focal segmental glomerulosclerosis (FSGS) and diffusely mild segmental mesangial proliferation. Plasma cell infiltration in the interstitium was not observed. Electron microscopic findings showed diffuse foot process effacement, localized involvement of subendothelial space widening with amorphous materials, and endothelial cell swelling. Lymph node biopsy findings denied Castleman disease. His skin regions and proteinuria were successfully treated with prednisolone and cyclosporine. The causal relationship between CSP and FSGS is unknown. However, increased serum levels of IL-6 and VEGF and decreased VEGF expression in the podocyte may contribute to renal lesions in patients with CSP. To our best knowledge, this is the first case of a patient with FSGS associated with CSP.

Entities:  

Keywords:  Castleman disease; Cutaneous and systemic plasmacytosis; Focal segmental glomerulosclerosis; Nephrotic syndrome

Year:  2017        PMID: 28939949      PMCID: PMC5694413          DOI: 10.1007/s13730-017-0276-z

Source DB:  PubMed          Journal:  CEN Case Rep        ISSN: 2192-4449


  16 in total

1.  Plasmacytosis: systemic or cutaneous, are they distinct?

Authors:  Y Tada; M Komine; S Suzuki; K Kikuchi; M Sasaki; N Kaneko; K Tamaki
Journal:  Acta Derm Venereol       Date:  2000-05       Impact factor: 4.437

2.  Castleman's tumours and production of autoantibody in paraneoplastic pemphigus.

Authors:  Liangchun Wang; Dingfang Bu; Yong Yang; Xixue Chen; Xuejun Zhu
Journal:  Lancet       Date:  2004-02-14       Impact factor: 79.321

3.  Are multicentric Castleman's disease with cutaneous plasmacytosis and systemic plasmacytosis the same entity?

Authors:  K Kayasut; A Le Tourneau; B Rio; F Bost-Bezeaud; L Heuberger; J Diebold; J Audouin
Journal:  Histopathology       Date:  2006-11       Impact factor: 5.087

Review 4.  Renal complications of Castleman's disease: report of two cases and analysis of 75 cases.

Authors:  Xiang-Gui Yuan; Wen Hu; Fei-Fei Chen; Bin-Feng Huang; Xiao-Ying Zhao
Journal:  Clin Exp Nephrol       Date:  2011-08-06       Impact factor: 2.801

5.  Renal involvement in a large cohort of Chinese patients with Castleman disease.

Authors:  Damin Xu; Jicheng Lv; Yujun Dong; Suxia Wang; Tao Su; Fude Zhou; Wanzhong Zou; Minghui Zhao; Hong Zhang
Journal:  Nephrol Dial Transplant       Date:  2011-05-19       Impact factor: 5.992

6.  Systemic and cutaneous plasmacytosis with multiple skin lesions and polyclonal hypergammaglobulinaemia: significant serum interleukin-6 levels.

Authors:  A Kodama; M Tani; K Hori; T Tozuka; T Matsui; M Ito; S Nakao; T Fujita; H Kobayashi
Journal:  Br J Dermatol       Date:  1992-07       Impact factor: 9.302

Review 7.  Glomerular disturbances in preeclampsia: disruption between glomerular endothelium and podocyte symbiosis.

Authors:  Daniel E Henao; Moin A Saleem; Angela P Cadavid
Journal:  Hypertens Pregnancy       Date:  2010-01       Impact factor: 2.108

8.  Systemic plasmacytosis. A syndrome of peculiar multiple skin eruptions, generalized lymphadenopathy, and polyclonal hypergammaglobulinemia.

Authors:  S Watanabe; K Ohara; A Kukita; S Mori
Journal:  Arch Dermatol       Date:  1986-11

9.  In vitro effects of interleukins on human mesangial cells: implications for glomerulonephritis.

Authors:  W P Chen; A Chen; C Y Lin
Journal:  J Pathol       Date:  1995-03       Impact factor: 7.996

10.  Multicentric Castleman disease with cutaneous manifestations: report of 2 cases and comparison with systemic plasmacytosis.

Authors:  Yuko Higashi; Takuro Kanekura; Ryoko Sakamoto; Yuji Mochitomi; Tamotsu Kanzaki
Journal:  Dermatology       Date:  2007       Impact factor: 5.366

View more
  2 in total

1.  STAT-3 signaling role in an experimental model of nephropathy induced by doxorubicin.

Authors:  Thabata Caroline de Oliveira Santos; Gabriel Pereira; Anna Gabrielle Gomes Coutinho; Halison Pereira Dos Santos Silva; Marcelo M S Lima; Fernando Augusto Lavezzo Dias; Danilo Cândido de Almeida; Débora Tavares Resende E Silva; Ricardo Fernandez Perez; Rafael Luiz Pereira
Journal:  Mol Cell Biochem       Date:  2022-10-06       Impact factor: 3.842

2.  Novel diagnostic and therapeutic techniques reveal changed metabolic profiles in recurrent focal segmental glomerulosclerosis.

Authors:  Janina Müller-Deile; George Sarau; Ahmed M Kotb; Christian Jaremenko; Ulrike E Rolle-Kampczyk; Christoph Daniel; Stefan Kalkhof; Silke H Christiansen; Mario Schiffer
Journal:  Sci Rep       Date:  2021-02-25       Impact factor: 4.379

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.